about
Direct epicardial shock wave therapy improves ventricular function and induces angiogenesis in ischemic heart failure.Is sonic Hedgehog involved in human fracture healing? --a prospective study on local and systemic concentrations of SHHElevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing.Hidden metabolic disturbances in women with normal glucose tolerance five years after gestational diabetes.Circulating Betatrophin Is Strongly Increased in Pregnancy and Gestational Diabetes MellitusThe Difference between Growth Factor Expression after Single and Multiple Fractures: Preliminary Results in Human Fracture Healing.Similarities in trabecular hypertrophy with site-specific differences in cortical morphology between men and women with type 2 diabetes mellitusGliptin therapy reduces hepatic and myocardial fat in type 2 diabetic patients Gliptins and cardiometabolic risk.Inhibition of stromal PlGF suppresses the growth of prostate cancer xenografts.Elevated levels of macrophage colony-stimulating factor in human fracture healing.Serum matrix metalloprotease-1 and vascular endothelial growth factor--a predict cardiac allograft rejection.The influence of non-osteogenic factors on the expression of M-CSF and VEGF during fracture healing.Strongly enhanced levels of sclerostin during human fracture healing.VEGF serum concentrations in patients with long bone fractures: a comparison between impaired and normal fracture healing.Donor myocardial apollon mRNA is associated with cardiac allograft rejection.Are OPG and RANKL involved in human fracture healing?Diabetes in HyperparathyroidismApollon/RNF41 myocardial messenger RNA diagnoses cardiac allograft apoptosis in rejectionGrowth factor release in extra- and intramedullary osteosynthesis following tibial fractureDonor serum SMARCAL1 concentrations predict primary graft dysfunction in cardiac transplantationEpicardial shock-wave therapy improves ventricular function in a porcine model of ischaemic heart disease
P50
Q33423318-463EAF3C-90E7-4D91-8186-18C456ABD668Q34680990-357569FF-9FBB-4BAC-A7D7-439C4862E2D0Q35103832-ACA1B91D-D5F4-4A9B-B16F-B2B900861E48Q35271525-EDC79D80-37CB-4644-B9AA-E579221FD27CQ35760956-854B592A-4812-4153-BD89-5A60F323243DQ35890498-FDF92B5A-C07C-48D6-B429-4B2A6309A305Q36338661-5460E791-7DDD-44EA-9643-F4DBE09CECBFQ38620945-AF927D7A-8386-4A16-A32C-195F169F1B01Q39100169-11352B2B-BF90-44D3-B0B8-024010B89E7DQ45906819-39E7983E-1C76-4860-BDFB-48306C80B3CAQ46207648-E3439B17-4116-43A3-9001-5195F7D1440AQ46895097-22F6BCD9-09D0-41B7-96DC-2FCC7CEDF5D8Q47896472-20A872B4-6432-4E29-B80E-D9AA5C14F761Q47919091-2885FEAD-9EC4-4E5D-B0E5-CB002B9282B2Q54428447-01A934ED-50D1-4961-BBD6-7D0C4EA12F5EQ58766665-46554247-ED4C-4E45-B99E-B8A4BE62DDECQ62774610-A2B470F5-4D66-4F84-B387-73EA5E6B379AQ82632571-E5ED1DAE-6291-4AFE-8809-886BE248C476Q82941457-924CF72D-0547-4ED0-A707-44140A18A73FQ84558795-634D2BE3-8448-4683-9D6A-A555A2E97F33Q87906195-A0D33B52-527E-4F1D-A92E-0E1AF4241AF5
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Anita Thomas
@ast
Anita Thomas
@en
Anita Thomas
@es
Anita Thomas
@nl
Anita Thomas
@sl
type
label
Anita Thomas
@ast
Anita Thomas
@en
Anita Thomas
@es
Anita Thomas
@nl
Anita Thomas
@sl
prefLabel
Anita Thomas
@ast
Anita Thomas
@en
Anita Thomas
@es
Anita Thomas
@nl
Anita Thomas
@sl
P106
P21
P214
2579150325525210090008
P31
P496
0000-0002-1679-3098
P734
P735
P7859
viaf-2579150325525210090008